Abstract
An up-to-date review of biological interventions in psychoses of childhood is presented here, together with occasional comments on efficacy based on the author’s experience. After brief mention of earlier forms of biological-organic treatment (psychosurgery, insulin, and electroconvulsive therapies), the review focuses on drug therapy. Relative prominence is given to major tranquilizers, lithium, and the hormones. Suitable information is also presented on hypnotics, anticonvulsants, sedatives, stimulants, antidepressant drugs, minor tranquilizers, hallucinogens, L-dopa, and vitamins. It is suggested that no specific drug is available for the treatment of any diagnostic category. Currently available drugs are most effective in reducing such symptoms as insomnia, hyperactivity, impulsivity, irritability, disorganized behavior, psychotic thought disorder, and certain types of aggressivity. The need for uniformity in the classification of child psychoses is stressed in light of its potential value in predicting responses of children to specific drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ajuriaguerra, J. de. Manuel de Psychiatrie de l’Enfant. Paris: Masson et Cie, 1971.
Anderson, W.M., and Dawson, J. The variability of plasma 17-hydroxycorticosteroid levels in affective illness and schizophrenia. Psychosomatic Research, 1965, 9, 237–248.
Angrist, B., Sathananthan, G., and Gershon, S. Behavioral effects of L-dopa in schizophrenic patients. Psychopharmacologia, 1973, 31, 1–12.
Annell, A. Insulin shock treatment in children with psychotic disturbances. Acta Psychotherapeutica Psychoanalytica Orthopoedica, 1955, 3, 193–205.
Annell, A. L. Manic-depressive illness in children and effect of treatment with lithium carbonate. Acta Paedopsychiatrica, 1969, 36, 292–361. (a).
Annell, A. L. Lithium in the treatment of children and adolescents. Acta Psychiatrica Scandinavica, 1969, 207 (Supp.), 19–30. (b).
Anton-Tay, F., and Wurtman, R. J. Brain monoamines and endocrine function. In L. Martini and W. F. Ganong (Eds.), Frontiers in neuroendocrinology. London: Oxford University Press, 1971.
Arbit, J., Boshes, B., and Blonsky, R. Behavior and mentation changes during therapy. In A. Barbeau and F. H. McDowell (Eds.), L-dopa and Parkinsonism. Philadephia: Davis, 1970.
Arnold, L. E., Kirilcuk, V., Corson, S. A., and Corson, E. O’L. Levoamphetamine and dextroamphetamine: Differential effect on aggression and hyperkinesis in children and dogs. American Journal of Psychiatry, 1973, 130, 165–170.
Arnold, L. E., and Wender, P. H. Levoamphetamine’s changing place in the treatment of children with behavior disorders. Pediatrics, 1975.
Arnold, L. E., Wender, P. W., McCloskey, K., and Snyder, S. H. Levoamphetamine and dextroamphetamine: Comparative efficacy in the hyperkinetic syndrome. Archives of General Psychiatry, 1972, 27, 816–822.
Balázs, R., Kovács, S., Cocks, W. A., Johnson, A. L., and Eayrs, J. T. Effect of thyroid hormone on the biochemical maturation of rat brain: Postnatal cell formation. Brain Research, 1971, 25, 555–570.
Ban, T. A. Nicotinic acid in psychiatry. Canadian Psychiatric Association Journal, 1971, 16, 413–431.
Ban, T. A., and Lehman, H. E. Nicotinic acid in the treatment of schizophrenias. Progress Report I. Toronto: Canadian Mental Health Association, 1970.
Bender, L. One hundred cases of childhood schizophrenia treated with electric shock. Transactions of the American Neurological Association, 1947, 72, 165–169.
Bender, L. Theory, and treatment of childhood schizophrenia. Acta Paedopsychiatrica, 1967, 34, 298–307.
Bender, L. The life course of children with schizophrenia. American Journal of Psychiatry. 1973, 130, 783–786.
Bender, L., Cobrinik, L., Faretra, G., and Sankar, D. V. S. The treatment of childhood schizophrenia with LSD and UML. In M. Rinkel (Ed.), Biological treatment of mental illness, New York: L. C. Page & Co., 1966.
Bender, L., and Cottington, F. The use of amphetamine sulfate (Benzedrine) in child psychiatry. American Journal of Psychiatry, 1942, 99, 116–121.
Bender, L., Goldschmidt, L., and Sankar, D. V. S. Treatment of autistic schizophrenic children with LSD-25 and UML-491. In J. Wortis (Ed.), Recent advances in biological psychiatry. New York: Plenum Press, 1962.
Bender, L., Faretra, G., and Cobrinik, L. LSD and UML treatment of hospitalized disturbed children. In J. Wortis (Ed.), Recent advances in biological psychiatry, New York: Plenum Press, 1963.
Bender, L., and Keeler, W. R. The body image of schizophrenic children following electroshock therapy. American Journal of Orthopsychiatry, 1952, 22, 335–355.
Bender, L., and Nichtern, S. Chemotherapy in child psychiatry. New York State Journal of Medicine, 1956, 56, 2791–2795.
Boullin, D. J., Coleman, M., and O’Brien, R. A. Abnormalities in platelet 5-hydroxytryp-tamine efflux in patients with infantile autism. Nature, 1970, 226, 371–372.
Boullin, D. J., Coleman, M., O’Brien, R. A., and Rimland, B. Laboratory predictions of infantile autism based on 5-HT efflux from platelets and their correlation with the Rimland E-2 score. Journal of Autism and Childhood Schizophrenia, 1971, 1, 63–71.
Bradley, C. The behavior of children receiving benzedrine. American Journal of Psychiatry, 1937, 94, 577–585.
Bradley, C., and Bowen, M. Amphetamine (Benzedrine) therapy of children’s behavior disorders. American Journal of Orthopsychiatry, 1941, 11, 92–103.
Brambilla, F., and Penati, G. Hormones and behavior in schizophrenia. In D. H. Ford (Ed.), Influence of hormones on the nervous system. Basel: Karger, 1971.
Butcher, L. L., Engel, J., and Fuxe, K. L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition. Journal of Pharmacy and Pharmacology, 1970, 22, 313–316.
Burk, H. W., and Menolascino, F. J. Haloperidol in emotionally disturbed mentally retarded individuals. American Journal of Psychiatry, 1968, 124, 1589–1591.
Campbell, J. D. Manic-depressive disease in children. Journal of the American Medical Association, 1955, 198, 154–157.
Campbell, M. A psychotic boy with self-mutilating behavior and the antiaggressive effect of lithium. Paper presented at the 20th Annual Meeting of the American Academy of Child Psychiatry, Washington, D. C., October 18–21, 1973.
Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. Thiothixene in young disturbed children. A pilot study.Archives of General Psychiatry, 1970, 23, 70–72.
Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. Study of molindone in disturbed preschool children. Current Therapeutic Research, 1971, 13, 28–33. (a).
Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. Imipramine in preschool autistic and schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1971, 1, 267–282. (b).
Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., and Koh, C. Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 343–358. (a).
Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., and Koh, C. Lithium-chlorpromazine: A controlled crossover study in hyperactive severely disturbed young children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 234–263. (b).
Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. Acute responses of schizophrenic children to a sedative and “stimulating” neuroleptic: A pharmacologic yardstick. Current Therapeutic Research, 1972, 14, 759–766. (c).
Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., and Koh, C. Liothyronine treatment in psychotic and nonpsychotic children under six years. Archives of General Psychiatry, 1973, 29, 602–608.
Campbell, M., Friedman, E., DeVito, E., Greenspan, L., and Collins, P. J. Blood serotonin in disturbed and brain damaged children. Journal of Autism and Childhood Schizophrenia, 1914, 4, 33–41.
Campbell, M., Friedman, E., Green, W. H., Collins, P. J., Small, A. M., and Breuer, H. Blood serotonin in schizophrenic children. A preliminary study. International Pharmaco-psychiatry, 1975.
Campbell, M., and Hersh, S. P. Observations on the vicissitudes of aggression in two siblings. Journal of Autism and Childhood Schizophrenia, 1971, 1, 398–410.
Campbell, M., and Shapiro, T. Therapy of psychiatric disorders in childhood. In R. I. Shader (Ed.), Manual of Psychiatric Therapeutics. Boston: Little, Brown and Company, 1975.
Campbell, M., Small, A. M., Collins, P. J., Friedman, E., David, R., and Genieser, N. B. Levodopa and levoamphetamine: a crossover study in schizophrenic children. Current Therapeutic Research, 1976, 18.
Cerletti, V. Old and new information about electroshock. American Journal of Psychiatry, 1950, 107, 87–94.
Cleckley, H. M., Sydenstricker, V. P., and Geeslin, L. E. Nicotinic acid in the treatment of atypical psychotic states. Journal of the American Medical Association, 1939, 112, 2107–2110.
Coleman, M. Serotonin levels in infant hypothyroidism. Lancet, 1970, 2, 365.
Coleman, M. Serotonin and central nervous system syndromes in childhood: A review. Journal of Autism and Childhood Schizophrenia, 1973, 3, 27–35.
Coleman, M., Campbell, M., Freedman, L. S., Roffman, M., Ebstein, R. P., and Goldstein, M. Serum dopamine-B-hydroxylase levels in Down’s syndrome. Clinical Genetics, 1974, 5, 312–315.
Conners, C. K. Deanol and behavior disorders in children: a critical review of the literature and recommended future studies for determining efficacy. Psychopharmacology Bulletin: Special Issue, Pharmacotherapy of Children, 1973, 188-195.
Corson, S. A., Corson, E. O’L., Kirilcuk, V., Knopp, W., and Arnold, L. E. Differential interaction of amphetamines and psychosocial factors in the modification of violent and hyperkinetic behavior and learning disability. Federal Proceedings, 1972, 31, 820.
Crane, G. E. Clinical psychopharmacology in its 20th year. Science, 1973, 181, 124–128.
Creak, M. Schizophrenic syndrome in childhood. Progress report of a working party. Cerebral Palsy Bulletin 1961, 3, 501–504.
Danziger, L. Thyroid therapy of schizophrenia. Diseases of the Nervous System, 1958, 19, 373–378.
Danziger, L., and Kindwall, J. A. Thyroid therapy in some mental disorders. Diseases of the Nervous System, 1953, 14, 3–13.
DiMascio, A., Soltys, J. J., and Shader, R. I. Psychotropic drug side effects in children. In R. I. Shader, and A. DiMascio (Eds.), Psychotropic Drug Side Effects, Baltimore: Williams & Wilkins Company, 1970, 235–260.
Dostal, T. Antiaggressive effect of lithium salts in mentally retarded adolescents. In A. L. Annell (Ed.), Depressive states in childhood and adolescence. Stockhohn: Almquist & Wiksell, 1972.
Durell, J., Libow, L. S., Kellam, S. G., and Shader, R. I. Interrelationships between regulation of thyroid gland function and psychosis. Association for Research in Nervous and Mental Diseases, 1963, 43, 387–399.
Dutton, G. The growth pattern of psychotic boys. British Journal of Psychiatry, 1964, 110, 101–103.
Dyson, W. L., and Barcai, A. Treatment of children of lithium responding parents. Current Therapeutic Research, 1970, 12, 286–290.
Eayrs, J. T. Developmental relationships between brain and thyroid. In R. P. Michael (Ed.), Endocrinology and human behavior. Oxford University Press, 1968.
Effron, A. S., and Freedman, A. M. The treatment of behavior disorders in children with benadryl. Journal of Pediatrics, 1953, 42, 261–266.
Eisenberg, L. The course of childhood schizophrenia. Archives of Neurology and Psychiatry, 1957, 78, 69–83.
Eisenberg, L. Role of drugs in treating disturbed children. Children, 1964, 2, 167–173.
Eisenberg, L. The classification of childhood psychosis reconsidered. Journal of Autism and Childhood Schizophrenia, 1972, 2, 338–342.
Eisenberg, L., and Conners, C. K. Psychopharmacology in childhood. In N. B. Talbot, J. Kagan, and L. Eisenberg (Eds.), Behavioral Science in Pediatric Medicine. Philadelphia: W. B. Saunders Company, 1971, 397–423.
Engelhardt, D. M., Polizos, P., and Margolis, R. A. The drug treatment of childhood psychosis. In W. L. Smith (Ed.), Drugs, development and cerebral function, Springfield, Ill.: Charles C. Thomas, 1972.
Engelhardt, D. M., Polizos, P., Waizer, J., and Hoffman, S. P. A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1973, 3, 128–137.
Everett, G. M., and Borcherding, J. W. L-dopa: Effect on concentrations of dopamine, norepinephrine and serotonin in brains of mice. Science, 1970, 168, 849–850.
Feldmesser-Reiss, E. E. The application of triiodothyronine in the treatment of mental disorders. Journal of Nervous and Mental Disease, 1958, 127, 540–545.
Fish, B. Drug therapy in child psychiatry: Pharmacological aspects. Comprehensive Psychiatry, 1960, 1, 212–227.
Fish, B. The influence of maturation and abnormal development on the responses of disturbed children to drugs. Proceedings of the Third World Congress of Psychiatry, 1963.
Fish, B. Drug use in psychiatric disorders in children. American Journal of Psychiatry, 1968, 124, 31–36.
Fish, B. Methodology in child psychopharmacology. In D. H. Efron, J. O. Cole, J. Levine, and J. R. Wittenborn (Eds.), Psychopharmacology, Review of Progress (Public Health Service Publication No. 1836). Washington, D.C.: United States Government Printing Office, 1968.
Fish, B. Psychopharmacologic responses of chronic schizophrenic adults as predictors of responses in young schizophrenic children. Psychopharmacology Bulletin, 1970, 6, 12–15.
Fish, B. The “one child, one drug” myth of stimulants in hyperkinesis. Importance of diagnostic categories in evaluating treatment. Archives of General Psychiatry, 1971, 25, 193–203.
Fish, B., Campbell, M., Shaprio, T., and Floyd, A., Jr. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: The value of less sedative antipsychotic agents. Current Therapeutic Research, 1969, 11, 589–595. (a).
Fish, B., Campbell, M., Shapiro, T., and Floyd, A., Jr. Schizophrenic children treated with methysergide (Sansert). Diseases of the Nervous System, 1969, 30, 534–540. (b).
Fish, B., Campbell, M., Shapiro, T., and Weinstein, J. Preliminary findings on thiothixene compared to other drugs in psychotic children under five years. In H. E. Lehmann and T. A. Ban (Eds.), The thioxanthenes: Modern problems of pharmacopsychiatry (Vol. 2). Basel, Switzerland: S. Karger, 1969. (c).
Fish, B., Shapiro, T., and Campbell, M. Long-term prognosis and the response of schizophrenic children to drug therapy: A controlled study of trifluoperazine. American Journal of Psychiatry, 1966, 123, 32–39.
Fox, W., Gobble, I. F., Clos, M., and Denison, E. A clinical comparison of trifluperidol, haloperidol and chlorpromazine. Current Therapeutic Research, 1964, 6, 409–415.
Freedman, A. M., Ebin, E. V., and Wilson, E. A. Autistic schizophrenic children. An experiment in the use of D-lysergic acid diethylamide (LSD-25). Archives of General Psychiatry, 1962, 6, 203–213.
Freeman, R. D. Drug effects on learning in children. A selective review of the past thirty years. Journal of Special Education 1966, 1, 17–43.
Freeman, R. D. Psychopharmacology and the retarded child. In F. Menolascino (Ed.), Psychiatric Approaches to Mental Retardation in Childhood. New York: Basic Books, 1970.
Freeman, W. Psychosurgery. In S. Arieti (Ed.), American handbook of psychiatry (Vol. II). New York: Basic Books, 1959.
Frommer, E. Depressive illness in childhood. In A. Coppen and A. Walk (Eds.), Recent developments in affective disorders. A symposium, British Journal of Psychiatry, 1968, Special Publication No. 2, 117-136.
Gallant, D. M., and Bishop, M. P. Molindone: A controlled evaluation in chronic schizophrenic patients. Current Therapeutic Research, 1968, 10, 441–447.
Gallant, D. M., Bishop, M. P., Nesselhoff, W., Jr., and Sprehe, D. J. Further observations on trifluperidol: A butyrophenone derivative. Psychopharmacologia, 1965, 7, 37–43.
Gallant, D. M., Bishop, M. P., and Shelton, W. A preliminary evaluation of P-4657B: A thioxanthene derivative. American Journal of Psychiatry, 1966, 123, 345–346.
Gallant, D. M., Bishop, M. P., Timmons, E., and Gould, A. R. Thiothixene (P-4657B): A controlled evaluation in chronic schizophrenic patients. Current Therapeutic Research, 1966, 8, 153–158.
Gershon, S., Holmberg, G., Mattson, E., and Marshall, A. Imipramine hydrochloride. Its effects on clinical, autonomic and psychological functions. Archives of General Psychiatry, 1962, 6, 96–101.
Gjessing, R. Beiträge zur Kenntniss der Pathophysiologie des katatonen Stupors. Archive für Psychiatrie und Nervenkrankheiten, 1932, 96, 319–392.
Gjessing, R. Disturbances of somatic functions in catatonia with a periodic course, and their compensation. Journal of Mental Science, 1938, 84, 608–621.
Gjessing, R. Beiträge zur Somatologie der periodischen Katatonie. Archive für Psychiatrie und Zeitschrift Neurologic 1953, 191, 191–326.
Goldfarb, W. Childhood Schizophrenia. Cambridge, Mass.: Harvard University Press, 1961.
Goodwin, F. K., Murphy, D. L., Brodie, H. K. H., and Bunney, W. E. L-dopa, catecholamines, and behavior: A clinical and biochemical study in depressed patients. Biological Psychiatry, 1970, 3, 341–366.
Gram, L. F., and Rafaelsen, O. J. Lithium treatment of psychotic children and adolescents. A controlled clinical trial. Acta Psychiatrica Scandinavica, 1972, 48, 253–260.
Greenbaum, G. H. An evaluation of niacinamide in the treatment of childhood schizophrenia, American Journal of Psychiatry, 1970, 127, 129–132.
Gurewitz, S., and Helme, W. H. Effects of electroconvulsive therapy on personality and intellectual functioning of the schizophrenic child. Journal of Nervous and Mental Disease, 1954, 120, 213–226.
Hartlage, L. C. Effects of chlorpromazine on learning. Psychological Bulletin, 1965, 64, 235–245.
Helper, M., Wilcott, R. C., and Garfield, S. L. Effects of chlorpromazine on learning and related processes in emotionally disturbed children. Journal of Consulting Psychology, 1963, 27, 1–9.
Heuyer, G., Lang, J. L., and Rivaille, C. J. Aspects cliniques des schizophrenies traitees par l’insuline. Revue de Neuropsychiatrie Infantile et d’Hygiene Mentale de l’Enfance, 1956, 4, 390–396.
Himwich, H. E., Kety, S. S., & Smythies, J. R. Amines and schizophrenia. New York: Pergamon Press, 1967.
Hoffer, A. Childhood schizophrenia: A case treated with nicotinic acid and nicotinamide. Schizophrenia, 1970, 2, 43–53.
Hoffer, A. Mechanisms of action of nicotonic acid and nicotinamide in the treatment of schizophrenia. In D. Hawkins and L. Pauling (Eds.), Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.
Hoskins, R. G. The biology of Schizophrenia. New York: Norton & Co., 1946.
Kanner, L. Autistic disturbances of affective contact. Nervous child, 1943, 2, 217–250.
Kety, S. S. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia. Seminars in Psychiatry, 1972, 4, 233–238.
Klein, D., and Fink, M. Psychiatric reaction to imipramine. American Journal of Psychiatry, 1962, 119, 432–438.
Kraft, I. A., Ardali, C., Duffy, J. H., Hart, J. T., and Pearce, P. A clinical study of chlordiazepoxide used in psychiatric disorders of children. International Journal of Neuropsychiatry, 1965, 1, 433–437.
Krantz, J. C., Jr., Truitt, E. B., Jr., Speers, L., and Ling, A. S. O. New pharmacoconvulsive agent. Science, 1957, 126, 353.
Kurtis, L. B. Clinical study of the response to nortriptyline on autistic children. International Journal of Neuropsychiatry, 1966, 2, 298–301.
Lapin, I. P., and Oxenkrug, G. F. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet, 1969, 1, 132–136.
LaVeck, G. D., and Buckley, P. The use of psychopharmacologic agents in retarded children with behavior disorders. Journal of Chronic Diseases, 1961, 13, 174–183.
LeVann, L. J. Chlordiazepoxide, a tranquilizer with anticonvulsant properties. Canadian Medical Association Journal, 1962, 86, 123–126.
LeVann, L. J. Haloperidol in the treatment of behavioral disorders in children and adolescents. Canadian Psychiatric Association Journal, 1969, 14, 217–220.
Lipman, R. S. Methodology of drug studies in children. Annual Meeting of the American Orthopsychiatric Association, Chicago, Illinois, March 21, 1968.
Lipman, R. S. The use of psychopharmacological agents in residential facilities for the retarded. In Frank J. Menolascino (Ed.), Psychiatric Approaches to Mental Retardation. New York: Basic Books, Inc., 1970, Chapter 15.
Lipton, M. A., Ban, T. A., Kane, F. J., Levine, J., Mosher, L. R., and Wittenborn, R. Megavitamin and orthomolecular therapy in psychiatry. Washington, D.C.: American Psychiatric Association, 1973.
Loranger, A. W., Goodell, H., Lee, J. H., and McDowell, F. Levo-dopa treatment of Parkinson’s syndrome. Improved intellectual functioning. Archives of General Psychiatry, 1972, 26, 163–168.
Martini, L., and Ganong, W. F. Frontiers in neuroendocrinology, 1971. London: Oxford University Press, 1971.
McAndrew, J. B., Case, A., and Treffert, D. A. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 75–91.
McCann, S. Mechanism of action of hypothalamic-hypophyseal stimulating and inhibiting hormones. In L. Martini and W. F. Ganong (Eds.), Frontiers in neuroendocrinology. London: Oxford University Press, 1971.
McGrath, S. D., O’Brien, P. F., Power, P. J., and Shea, J. R. Nicotinamide treatment of schizophrenia. Report of a multihospital controlled trial. Schizophrenia Bulletin, 1972, 5, 74–76.
Moniz, E. Tentative operatoires dans le traitement de certaines psychoses. Paris: Masson et Cie, 1936.
Mosher, L. R. Nicotinic acid side effects and toxicity. A review. American Journal of Psychiatry, 1970, 126, 1290–1296.
Murphy, D. L. Amine precursors, amines and false neurotransmitters in depressed patients. American Journal of Psychiatry, 1972, 129, 141–148. (a).
Murphy, D. L. L-dopa, behavioral activation and psychopathology. In I. J. Kopin (Ed.), Neurotransmitters. Baltimore: Williams & Wilkins, 1972. (b).
Ng, K. Y., Chase, T. N., Colburn, R. W., and Kopin, K. J. L-dopa-induced release of cerebralmonoamines. Science, 1970, 170, 76–77.
O’Brien, C. P., DiGiacomo, J. N., Fahn, S., and Schwarz, G. A. Mental effects of high-dosage levodopa. Archives of General Psychiatry, 1971, 24, 61–64.
Oettinger, L. Chlorprothixene in the management of problem children. Diseases of the Nervous System, 1962, 23, 1–4.
Osmond, H., and Hoffer, A. Massive niacin treatment in schizophrenia. Review of a nine-year study. Lancet, 1962, 1, 316–319.
Osmond, H. The background to the niacin treatment. In D. Hawkins and L. Pauling (Eds.), Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.
Pauling, L. Orthomolecular psychiatry. Science, 1968, 160, 265–271.
Persky, H., Zuckerman, M., and Curtis, G. C. Endocrine functions in emotionally disturbed and normal men. Journal of Nervous and Mental Disease, 1968, 146, 488–497.
Piggott, L. R., and Gottlieb, J. S. Childhood schizophrenia-what is it? Journal of Autism and Childhood Schizophrenia, 1973, 3, 96–105.
Pilkington, T. L. Comparative effects of librium and taractan on behavior disorders of mentally retarded children. Diseases of the Nervous System, 1961, 22, 573–575. (a).
Pilkington, T. L. The effects of librium and taractan on the behavior of psychotically disturbed mentally retarded children. Psychopharmacology Abstracts, 1961, 61, 575. (b).
Polizos, P., Engelhardt, D. M., Hoffman, S. P., and Waizer, J. Neurological consequences of psychotropic drug withdrawal in schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1973, 3, 247–253.
Pollack, M., Klein, D. F., Willner, A., Blumberg, A., and Fink, M. Imipramine-induced behavioral disorganization in schizophrenic patients: Physiological and psychological correlates. In J. Wortis (Ed.), Recent advances in biological psychiatry. New York: Plenum Press, 1965.
Prange, A. J., Jr., Wilson, I. C., Rabon, A. M., and Lipton, M. A. Enhancement of imipramine antidepressant activity by thyroid hormone. American Journal of Psychiatry, 1969, 126, 457–469.
Prange, A. J., Jr., and Lipton, M. A. Hormones and behavior: Some principles and findings. In R. I. Shader (Ed.), Psychiatric complications of medical drugs. New York: Raven Press, 1972.
Ramsey, R. A., Ban, T. A., Lehmann, H. E., Saxena, B. M., and Bennett, J. Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients. Canadian Medical Association Journal, 1970, 102, 939–942.
Reiss, M. Correlations between changes in mental states and thyroid activity after different forms of treatment. Journal of Mental Sciences, 1954, 100, 687–703.
Reiss, M. (Ed.) Psychoendocrinology. New York: Grune & Stratton, 1958.
Reiss, M. Clinical and basic neuroendocrine investigations in some states of mental retardation. In D. H. Ford (Ed.), Influence on hormones on the nervous system. Basel: Karger, 1971.
Rimland, B. Infantile Autism. New York: Appleton-Century-Crofts, 1964.
Rimland, B. High-dosage levels of certain vitamins in the treatment of children with severe mental disorders. In D. Hawkins and L. Pauling (Eds.), Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.
Ritvo, E. R., Yuwiler, A., Geller, E., Kales, A., Rashkis, S., Schicor, A., Plotkin, S., Axelrod, R., and Howard, C. Effects of L-dopa in autism. Journal of Autism and Childhood Schizophrenia, 1971, 1, 190–205.
Ritvo, E. R., Yuwiler, A., Geller, E., Ornitz, E. M., Saeger, K., and Plotkin, S. Increased blood serotonin and platelets in early infantile autism. Archives of General Psychiatry, 1970, 23, 566–572.
Rolo, A., Krinsky, L., Abramson, H., and Goldfarb, L. Preliminary method study of LSD with children. International journal of Neuropsychiatry, 1965, 1, 552–555.
Ruttenberg, B. A., and Steg, N. Vulnerability and risk-a continuum of etiology in the clinical syndrome of infantile autism. Paper presented at 51st Annual Meeting of the American Orthopsychiatric Association, Workshop 53, San Francisco, California, April 8-12, 1974.
Rutter, M. Childhood schizophrenia reconsidered. Journal of Autism and Childhood Schizophrenia, 1972, 2, 315–337.
Sachar, E. J. Psychoendocrine aspects of acute schizophrenic reactions. Psychosomatic Medicine, 1963, 25, 510–537.
Sachar, E. J., Harmatz, J., Bergen, H., and Cohler, J. Corticosteroid responses to milieu therapy of chronic schizophrenics. Archives of General Psychiatry, 1966, 15, 310–319.
Sachar, E. J., Hellman, L., Roffwarg, H. P., Halpern, F. S., Fukushima, D. K., and Gallagher, T. F. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Archives of General Psychiatry, 1973, 28, 19–24.
Safer, D. J., and Allen, R. P. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics, 1973, 51, 660–667.
Sakel, M. The pharmacological shock treatment of schizophrenia. New York: Nervous and Mental Diseases Publishing Co., 1938.
Schain, R. J., and Freedman, D. X. Studies of 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 1961, 58, 315–320.
Schapiro, S. Influence of hormones and environmental stimulation of brain development. In D. H. Ford (Ed.), Influence of hormones on the nervous system. Basel: S. Karger, 1971.
Schaub, C. L., Soulairac, A., and Franchimont, P. Action of chlorpromazine on the hypothalamo-somato-tropic and the hypotholamo-corticotropic axis in man. In D. H. Ford (Ed.), Influence of Hormones on the Nervous System. Basel: Karger, 1971. Pp. 121–139.
Schildkraut, J. J., and Kety, S. S. Biogenic amines and emotion. Pharmacological studies suggest a relationship between brain biogenic amines and affective state. Science, 1967, 156, 21–30.
Schou, M. Lithium in psychiatric therapy and prophylaxis. A review with special regard to its use in children. In A. L. Annell (Ed.), Depressive states in childhood and adolescence. Stockholm: Almquist & Wiksell, 1972.
Sheard, M. H. Behavioral effects of p-chlorophenylalanine in rats: Inhibition by lithium. Communications in Behavioral Biology, 1970, 5, 71–73. (a).
Sheard, M. H. Effect of lithium on foot shock aggression in rats. Nature, 1970, 228, 284–285. (b).
Sheard, M. The effect of lithium on behavior. Communications in Contemporary Psychiatry, 1971, 1, 1–6. (a).
Sheard, M. H. Effect of lithium on human aggression. Nature, 1971, 230, 113–114. (b).
Sherman, L., Kim, S., Benjamin, F. and Kolodny, H. D. Effect of chlorpromazine on serum growth-hormone concentration in man. New England Journal of Medicine, 1971, 284, 72–74.
Sherwin, A. C., Flach, F. F., and Stokes, P. E. Treatment of psychoses in childhood with triiodothyronine. American Journal of Psychiatry, 1958, 115, 166–167.
Silver, A. A. Management of children with schizophrenia. American Journal of Psychotherapy, 1955, 9, 196–215.
Simeon, J., Saletu, B., Saletu, M., Itil, T. M. and DaSilva, J. Thiothixene in childhood psychoses. Paper presented at the Third International Symposium on Phenothiazines, Rockville, Maryland, 1973.
Simmons, J. Q., III, Leiken, S. J., Lovaas, O. I., Schaeffer, B., and Perloff, B. Modification of autistic behavior with LSD-25. American Journal of Psychiatry, 1966, 122, 1201–1211.
Simon, G. B., and Gillies, S. M. Some physical characteristics of a group of psychotic children. British Journal of Psychiatry, 1964, 110, 104.
Simpson, G. M., Cranswick, E. H., and Blair, J. H. Thyroid indices in chronic schizophrenia. Journal of Nervous and Mental Disease, 1963, 137, 582–590.
Simpson, G. M., Cranswick, E. H., and Blair, J. H. Thyroid indices in chronic schizophrenia. II. Journal of Nervous and Mental Disease, 1964, 138, 581–585.
Simpson, G. M., and Igbal, J. A preliminary study of thiothixene in chronic schizophrenics. Current Therapeutic Research, 1965, 7, 310–314.
Simpson, G. M., and Krakov, L. A preliminary study of molindone (EN-1733A) in chronic schizophrenia. Current Therapeutic Research, 1968, 10, 41–46.
Skynner, A. C. R. Effect of chlordiazepoxide. Lancet, 1961, 1, 1110.
Snyder, S. H., Taylor, K. M., Coyle, J. T., and Meyerhoff, J. L. The role of brain dopamine in behavioral regulation and the actions of psycho tropic drugs. American Journal of Psychiatry, 1970, 127, 199–207.
Sokoloff, L., and Roberts, P. Biochemical mechanism of the action of thyroid hormones in nervous and other tissues. In D. H. Ford (Ed.), Influence of hormones on the nervous system. Basel: Karger, 1971.
Sprague, R. L., and Werry, J. S. Methodology of psychopharmacological studies with the retarded. In N. R. Ellis (Ed.), International Review of Research in Mental Retardation (Vol. 5). New York: Academic Press, 1971. Pp. 147–219.
Sugerman, A. A., and Herrmann, J. Molindone: An indole derivative with anti-psychotic activity. Clinical Pharmacology and Therapeutics, 1967, 8, 261–265.
Sugerman, A. A., Stolberg, H., and Hermann, J. A pilot study of P-4657B in chronic schizophrenics. Current Therapeutic Research, 1965, 7, 310–314.
Taylor, K. M., and Snyder, S. H. Amphetamine: Differentiation by D-and L-isomers of behavior involving brain norepinephrine or dopamine. Science, 1970, 168, 1487–1489.
Tupin, J. P., and Smith, D. B. The long-term use of lithium in aggressive prisoners. Paper presented at the Meeting of the Early Clinical Drug Evaluation Unit, Psycho-pharmacology Research Branch, NIMH, Catonsville, Maryland, June 1972.
Waizer, J., Polizos, P., Hoffman, S. P., Engelhardt, D. M., and Margolis, R. A. A single-blind evaluation of thiothixene with outpatient schizophrenic children. Journal of Autism and Childhood Schizophrenia, 1972, 2, 378–386.
Weischer, M. L. On the antiaggressive effect of lithium. Psychopharmacologia, 1969, 15, 245–254.
Werry, J. S., Weiss, G., Douglas, V., and Martin, J. Studies on the hyperactive child III: The effect of chlorpromazine upon behavior and learning ability. Journal of American Academy of Child Psychiatry, 1966, 5, 292–312.
Whitehead, P. L., and Clark, L. D. Effect of lithium carbonate, placebo and thioridazine on hyperactive children. American Journal of Psychiatry, 1970, 127, 824–825.
Williams, J. M., and Freeman, W. Evaluation of lobotomy with special reference to children. Association for Research in Nervous and Mental Disease, Proceedings, 1953, 31, 311.
Wilson, M. B., Prange, A. J., Jr., McClane, T. K., Rabon, A. M., and Lipton, M. A. Thyroid hormone enhancement of imipramine in nonretarded depressions. New England Journal of Medicine, 1970, 282, 1063–1067.
Wilson, I. C., Prange, A. J., Jr., and Lara, P. P. T3 alone in depressed adults. Paper presented at the Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 1972.
Wittenborn, J. R., Weber, E. S. P., and Brown, M. Niacin in the long-term treatment of schizophrenia. Archives of General Psychiatry, 1973, 28, 308–315.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Campbell, M. (1976). Biological Interventions in Psychoses of Childhood. In: Schopler, E., Reichler, R.J. (eds) Psychopathology and Child Development. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2187-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2187-3_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2189-7
Online ISBN: 978-1-4684-2187-3
eBook Packages: Springer Book Archive